Switching EC to non-prescription status and unwanted pregnancy

ByCristina Puig

January 2020. The paper Switching emergency contraceptives to non-prescription status and unwanted pregnancy among adult and teenage women: A long-term European comparative study was published in the South Eastern European Journal of Public Health and is available as open access.

This study’s assessed abortion/birth rates among adult and teenage women in Europe before and after the switch of EC to non-prescription status. Findings suggest, among others, that the switch contributed to reduce abortion and live birth rates among teenagers.

 Click here to read the paper. 

 

Similar Posts

|

EC101 at the International Conference of Family Planning

ByCristina Puig

November 2022.  The International Conference on Family Planning, the world’s largest gathering on family planning and reproductive health, took place in Thailand on 14-17 November 2022. ECEC is proud to have participated in the organization of one segment of the Live Community Programming, that revised the basics of emergency contraception. The segment, called “Emergency contraception…

|

War in Ukraine: European Parliament calls to ensure access to emergency contraception for women throughout conflict and displacement.

ByCristina Puig

May 2022. On May 5th, the European Parliament adopted a resolution that strongly condemns the use of sexual and gender-based violence as a weapon of war. Members of the European Parliament (MEPs) call on the EU and host and transit countries to guarantee access to sexual and reproductive health and rights services, particularly emergency contraception,…

|

Over-the-counter provision of EC pills is feasible

ByCristina Puig

March 2022.  A new systematic review of over-the-counter (OTC) provision of emergency contraception pills (ECPs), concludes that it is feasible and acceptable, and that it may increase access to and timely use of effective contraception. Evidence suggests that OTC provision of ECPs do not substantively change reproductive health outcomes. This review expands the evidence supporting…

|

First participatory survey on pharmacy access to EC in Europe.

ByCristina Puig

Help us learn more about how real access to emergency contraception (EC) is in Europe!  July / Sept 2019. The European Youth Network on Sexual and Reproductive Rights (YouAct) and ECEC, launch the first participatory survey on pharmacy access to EC in Europe. With this effort, we want to: Learn how EC products are placed and stocked in…

|

“EC in the COVID-19 era: advance access is more important than ever”

ByCristina Puig

May 2020. The American Society for Emergency Contraception (ASEC) publishes “EC in the COVID-19 era: advance access is more important than ever”. While EC access in the US and most European countries differ (UPA EC pills are still a prescription product in the US) ASEC overall recommendation is still valid in our context: know where…

|

Recommendations for quickstarting hormonal contraception after UPA EC

ByCristina Puig

Over the past year, there have been discussions around whether hormonal contraception should be resumed immediately after the intake of UPA EC. The concern is that using a progestin-containing contraceptive could counteract the effects of UPA EC. UPA is an anti-progestin that works by delaying or inhibiting ovulation; if a progestin-containing contraceptive is administered at the…